We completed a phase 2a trial, the clear mind trial, which demonstrated the potential benefits of lomecelb over placebo to maintain cognitive function and slow deterioration of brain structure atrophy, with no safety issues observed. Newsletters We completed a phase 2a trial, the clear mind trial, which demonstrated the potential benefits of lomecelb over placebo to maintain cognitive function and slow deterioration of brain structure atrophy, with no safety issues observed. Eventi Podcasts Video Africanews
We completed a phase 2a trial, the clear mind trial, which demonstrated the potential benefits of lomecelb over placebo to maintain cognitive function and slow deterioration of brain structure atrophy, with no safety issues observed.
Seguiteci
Le notizie del giorno | 23 febbraio 2026 - Pomeridiane

We completed a phase 2a trial, the clear mind trial, which demonstrated the potential benefits of lomecelb over placebo to maintain cognitive function and slow deterioration of brain structure atrophy, with no safety issues observed.

Ultimo aggiornamento:

Segui l'attualità dall'Europa e dal mondo del 23 febbraio 2026. Ricevi le ultime notizie su economia, spettacolo, politica, cultura, viaggi.

Scelti per voi

PUBBLICITÀ
PUBBLICITÀ

Ultimi Video

PUBBLICITÀ
PUBBLICITÀ
PUBBLICITÀ